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Background: The purpose of this pilot study was to evaluate for the first time the effect of 75/25 w/w nano-
Hydroxyapatite/Chitosan (nHAp/CS) scaffolds on Guided Bone Regeneration (GBR) in rat calvarial critical-sized 
defects (CSDs). 
Material and Methods: Six adult Sprague Dawley rats, 3 males and 3 females, were used. Two CSDs, full thick-
ness and 5mm in diameter, were trephined in both sides of the parietal bone. The right CSD was filled with nHAp/
CS scaffold, while the left CSD remained empty, as the control group. The wound was sutured in layers. Rats were 
euthanized with diethyl ether inhalation at 2, 4 and 8 weeks after surgical procedure. Histological and histomor-
phometric analysis was performed within distinct regions of interest (ROI): the lateral area inward of the middle 
sagittal seam; the lateral area outward of the middle sagittal seam and the central area.
Results: The mean surface of newly formed bone (in μm2) in the lateral area inward of the middle sagittal seam of 
all rats was significantly higher (P=0.039) in the experimental group (91733.00±38855.60) than the control group 
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(46762.17±25507.97). The NOex-c, defined as total number of osteocytes (OST) in newly formed bone surface in ex-
perimental group [experimental OST] minus the total number of osteocytes in newly formed bone surface in control 
group [control OST], was significantly greater (P=0.029) at 4th week post-surgery. Within the experimental group, a 
statistically significant increase (P=0.042) in the surface of newly formed bone was noticed in rats euthanized in 4th 
week compared with rats euthanized in 2nd week after surgery in the lateral area inward of the middle sagittal seam.
Conclusions: The results of this study suggest that 75/25 w/w nHAp/CS scaffolds should be considered as a suitable 
biomaterial for GBR.
Key words: Hydroxyapatite, chitosan, critical sized defect, rats, bone regeneration.
Introduction
Various bone graft materials provide an osteoconduc-
tive matrix that enhances bone formation in hard tissue 
critical-sized defects (CSDs) (1). For successful applica-
tion, those bone graft materials should possess charac-
teristics close to those of natural bone, as well as a pore 
structure that would allow the migration of osteoblasts 
and promote their growth and proliferation (2). Given 
that bone is a highly specialized composite material 
consisting of hydroxyapatite embedded in a polymeric 
matrix of collagen and various non-collageneous pro-
teins, the current research efforts are mainly focused 
on the development of composite hydroxyapatite/poly-
mer porous scaffolds. Polymers of natural origin such as 
gelatin, collagen, proteoglycans, alginates and chitosan 
(CS) have been employed in the development of such 
scaffolds (3,4). Among them, CS promotes osteocon-
duction, ability to produce porous structures and cell 
ingrowth, antibacterial nature and minimal foreign 
body reaction. In addition, CS has structural similarity 
to glycosaminoglycans (5,6) and permits the incorpora-
tion of bioceramics, such as hydroxyapatite (7).
Synthetic hydroxyapatite (HAp) has been used in Guid-
ed Bone Regeneration (GBR) as a bone substitute, as 
it is very similar to biogenic apatite (8) and has excel-
lent biocompatibility, non-toxicity, non-immunogenic 
behavior, and osteoconductive ability (9,10). HAp par-
ticles suitable for bone tissue regeneration should have 
narrow crystal size distribution, high purity and high 
specific surface area (11). In recent studies, biomateri-
als have been used in GBR as porous scaffolds, usually 
consisting of nano-Hydroxyapatite (nHAp) and chito-
san (12-16). Nano-hydroxyapatite/Chitosan (nHAp/
CS) is a composite, inorganic/organic scaffold for GBR 
that combines improved mechanical properties and the 
desired properties of the ideal biomaterial, e.g. hemo-
compatibility, biocompatibility and osteoconductivity 
equivalent to natural bone (1,17). Due to its controlled 
porous structure, the scaffold promotes cell prolifera-
tion, growth and migration, thus, representing a promis-
ing tool in tissue engineering applications (17).
The study of GBR often involves experimental in vivo 
models. Rat calvaria is one of the most used pre-clin-
ical settings for the testing of osseous graft materials. 
Rat calvarial defect model is relatively inexpensive and 
provides adequate anatomical access and easy surgical 
procedure (18).
Previously, the biological behavior of varying weight 
(w) proportions of nHAp/CS, i.e. 20/80 w/w, 30/70 w/w, 
50/50 w/w and 80/20 w/w, in rats has been investigated. 
The nHAp/CS composites were biocompatible and bio-
degradable, with sufficient elasticity and flexibility (13). 
It should be noted that an increased hydroxyapatite con-
centration exceeding 80% has been reported to result in 
friable scaffolds in vitro (17). In contrast, scaffolds with 
a nHAp/CS concentration of 75/25 w/w have shown in-
creased physico-mechanical characteristics (17). Based 
on these results of the in vitro study of Tsiourvas et al. 
(17), we hypothesized that nHAp/CS 75/25 w/w may 
show also increased physico-mechanical and osteocon-
ductive characteristics when applied to an in vivo rat cal-
varial model.
The objectives of this pilot study were to evaluate for 
the first time the effect of 75/25 w/w nHAp/CS scaffolds 
on new bone formation and to estimate the biological 
behavior of nHAp/CS scaffolds in rat calvarial critical-
sized defects (CSDs). The new bone formation and the 
total number of osteocytes in new bone surface were 
analyzed comparing the CSDs loaded with nHAp/CS 
scaffolds with empty CSDs.
Material and Methods
This was an in vivo experimental pilot study, since there 
is no background in the use of the biomaterial nHAp/CS 
75/25 w/w.
- Fabrication of Chitosan/nano-Hydroxyapatite compo-
site scaffolds
Nanoparticles of hydroxyapatite (nHAp) were synthe-
sized according to a previous work (19) in the presence 
of hyperbranched polyethylene imine (Lupasol G100, 
BASF, Greece), in order to regulate the size and mor-
phology of hydroxyapatite crystals. This method affords 
hydroxyapatite nanoparticles having a monodisperse 
size distribution that can be utilized for the preparation 
of water colloidal dispersions with concentrations up 
to 9% w/w, which exhibit excellent stability, remaining 
stable even after storage (50C) for more than one year. 
These features are essential for the preparation of well-
dispersed HAp/CS composites.
Composite porous scaffolds were developed by prepar-
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ing a 3% w/w chitosan (Sigma-Aldrich, high molecular 
weight, deacetylation degree ≥75.0%, Milwaukee, WI, 
USA) solution in aqueous acetic acid (1.5% w/w) and 
adding nHAp to a final HAp/CS weight ratio of 75/25 
(17). The resulting thick slurry was thoroughly mixed and 
molded in glass tubes (5mm i.d.) that were subsequently 
frozen at -25oC and lyophilized. After lyophilization the 
resulting nHAp/CS cylindrical porous scaffolds (5mm in 
diameter) were cut to disks of 1mm thickness, ethanol 
sterilized and extensively washed with sterile phosphate 
buffer saline inside a laminar flow cabinet. Porosity and 
total pore volume were found to be 85±2% and 5.0±0.5 
ml/g, respectively, as established by determining the vol-
ume of liquid infused in the pores of dried scaffolds (20).
- Animals
Six adult Sprague Dawley rats (3 males and 3 females, 
3 month-old), weighing more than 250g, were provided 
by the Laboratory of Experimental Surgery of the Medi-
cal School of the National and Kapodistrian University 
of Athens. The rats grew up in stable conditions of heat-
ing, ventilation and relative humidity, while their health 
was daily monitored by a specialized veterinarian. The 
study was approved by the Directorate of Agricultural 
and Veterinary Policy and Laboratory of Experimental 
Surgery (protocol number 1181/2-03-2017, registration 
code EL25 BIO05, Athens, Greece) and its protocol was 
in accordance with EU Directive 2010/63/EU, based on 
the concept of replacement, reduction and refinement of 
animal studies (“the 3R principle”) (21).
Sample size was minimized in accordance with the 
aims of “Animal Research: Reporting of In Vivo Ex-
perimental guidelines (ARRIVE)”. The sample size 
was estimated with a power analysis (Power 1-β err 
prob=0.6949) using one-way ANOVA Fixed effects 
(IBM SPSS 25.0, IBM Corp., Armonk, N.Y., USA). The 
introduction of the gender as a variable took place in or-
der to limit the use of only male rats, in agreement with 
the National Institute of Health (NIH, NOT-OD-102). 
Study groups included two rats (1 male, 1 female) for 
each time period until euthanasia (2, 4and 8 weeks, re-
spectively). The number of animals used was compa-
rable to that of previous bone regeneration studies (21).
Bilateral CSDs were made in each rat: the right CSD 
represented the experimental group, loaded with nHAp/
CS scaffold; the left CSD was left empty of biomaterial 
as the control group. Thus, in total, 12 CSDs were made.
- Surgical procedure
General anesthesia was induced by intramuscular in-
jection of xylazine 5mg/kg (Rompun, Bayer Animal 
Health, Leverkusen, Germany) and ketamine hydro-
chloride 100mg(kg (Imalgene 1000, Merial, Lyon, 
France). After shaving and disinfecting with povidone-
iodine (Betadine Solution, Lavipharm, Athens, Greece) 
a 2cm-sized longitudinal mid-sagittal skin incision was 
made in the scalp. The musculature and the mucoperios-
teum were exposed and dissected (22,23). Using a den-
tal drill (Implantmed, W&H, Bürmoos, Austria) with a 
5 mm diameter dental trephine burr (MT-00500, MIS, 
Savion, Israel), two symmetrical round bone defects were 
made in the dorsal part of the right and the left parietal 
bones (Fig. 1A), under sterile saline irrigation (Sodium 
Chloride 0.9% Intravenous Infusion, BIOSER, Greece). 
nHAp/CS was placed in the right CSD (Fig. 1B), while 
the left CSD was left empty. The wound was sutured 
in layers with 3-0 polyglactin 910 (Coated VICRYL, 
Ethicon, Johnson&Johnson, USA). Postoperative care 
included antimicrobial treatment by intramuscular injec-
tion with enrofloxacin 2.5mg/kg (Baytril 5%, Bayer Ani-
mal Health GmbH D-51368, Leverkusen, Germany) and 
analgesic and anti-inflammatory treatment with caprofen 
(Rimadyl, Pfizer, USA) one time per day, for five days.
Rats were euthanized with diethyl ether (Sigma Aldrich, 
USA) inhalation at 2, 4 and 8 weeks, respectively (Fig. 1C), 
after surgical procedure. Calvaria of rats were excised us-
ing a surgical sawmill, and two horizontal and two vertical 
osteotomies were performed that included both the pari-
etal bones and parts of occipital and frontal bones.
- Histological analysis
Specimens were immediately fixed in 10% neutral buff-
ered formalin (Formaldehyde solution, Sigma Aldrich, 
USA) for one day and then decalcified in EDTA-based 
solution (MicroDec, Diapath, Italy) for seven days. His-
tological sections of 5μm were prepared from the mid-
point of the defects in the coronal plane (Fig. 1D) and 
were stained with hematoxylin-eosin (H&E) (23). 
- Histomorphometrical analysis
Histomorphometric assessment was performed by a certi-
fied digital image analyzer in cytomorphology, who was 
blind to the intervention. Digital image analysis required 
a semi-automated system with Intel Pentium V, Digital 
Camera Sony 1600×1200 and Microscope Olympus CX-
31 hardware features, and the following software: Win-
dows XP/Windows XP/NIS-Elements Software AR v3.0, 
Nikon Corp, Tokyo, Japan. Parameters assessed were the 
new bone formation in CSDs expressed as μm2 and the 
NOex-c, defined as total number of osteocytes (OST) in 
newly formed bone surface in experimental group [ex-
perimental OST] minus the total number of osteocytes in 
newly formed bone surface in control group [control OST]. 
This number may be considered as a surrogate marker of 
bone formation speed, as the more rapid the bone forma-
tion the more osteocytes are present. For those purposes, 
division of the corresponding histological sections was 
implemented by splitting the whole image in continuous 
areas. A digital drawing and crop tool separated the area 
of interest from the near environment and at the final stage 
digital analysis was performed (Fig. 2). 
As bone regeneration process from the edge towards the 
center of the defect, bone formation was evaluated sepa-
rately on the central and two lateral areas of the defect 
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Fig. 1. In the dorsal part of the right and the left pari-
etal bones (A) two symmetrical round bone defects were 
made using a dental drill with a 5mm diameter dental tre-
phine burr and (B) the biomaterial nHAp/CS was placed 
in the right defect. (C) A timeline diagram showing the 
distribution of the rats into the groups. (D) Ηistological 
sections of 5μm were prepared from the mid-point of the 
defects in the coronal plane.
Fig. 2. A digital drawing and crop tool separated the area of interest from the near environment and at the final stage digital 
analysis was performed and area measurements were reported as square px/μm (μm2).
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(22,23), defined as Regions of Interest (ROI), as follows: 
(a) lateral area inward of the middle sagittal seam (late-
ral 1, l1); (b) lateral area outward of the middle sagittal 
seam (lateral 2, l2) and (c) central area (c, central) (Fig. 
2). New bone surface and NOex-c were calculated for 
each ROI in H&E-stained sections with original mag-
nifications x100.
- Statistical analysis
The data, i.e. new bone surface as μm2 and total number 
of osteocytes, were estimated as mean±Standard Devia-
tion (SD). The calculation of the sample size was made 
in accordance with the aims of ARRIVE guidelines, 
based on previous literature (21). A one–way ANOVA 
and Student’s paired t-test using IBM SPSS 25.0 were 
applied to determine possible significant differences, 
considering a level of significance of P<0.05.
Results
- Animals
During and after surgical procedure, no visible com-
plication was seen in any experimental animal. Wound 
healing was excellent in all rats.
- Histological results
Homogeneity of the size of all the CSDs was evaluated 
by statistical analysis. The total surface of all CSDs (in 
μm2) were similar, as there were no statistically sig-
nificant differences between experimental and control 
groups (P>0.05), in relation to sex (P>0.05) and to the 
euthanasia time (2, 4, 8 weeks) (P>0.05). 
12 CSDs were available for microscopic evaluation: the 
experimental group, consisting of 6 CSDs on the right 
side, where nHAp/CS scaffolds were placed; and the 
control group, consisting of 6 CSDs on the left side that 
was left empty of the nHAp/CS scaffolds.
Newly formed bone appeared as fibrous bone with many 
osteocytic lacunae. Therefore it could be easily distin-
guished by the preexisting calvarial bone at the edges of 
the CSDs that was lamellar and sparsely cellular. Resid-
ual graft material was observed in the CDSs of all rats in 
the experimental group, but due to the small sample size 
no effort to quantify it in relation to time interval was 
made. Scaffolds of nHAp/CS showed good integration at 
2, 4 and 8 weeks, as shown by lack of pus formation, 
necrosis, or foreign body granuloma formation in any of 
the CSD of the experimental or control group (Table 1).
In rats euthanized at 2 weeks after surgery, some newly 
formed bone was observed on the l1 and l2 areas of both 
experimental and control group, but not in the central 
area (Fig. 3A, B). Mild inflammatory infiltration and 
few osteoclast-like, multinucleated giant cells were ob-
served around the biomaterial. 
In rats euthanized at 4 weeks after surgical procedure, 
more newly formed bone was observed on the l1 and l2 
areas of the experimental and the control group. Newly 
bone formation in the central area of CSD with the bio-
material was observed in the female rat (Fig. 3C, D). 
There was no inflammatory infiltration or multinucle-
ated giant cells in relation to the biomaterial. 
In rats euthanized at 8 weeks after surgery, newly 
formed bone was observed on the l1 and l2 areas of both 
groups. Bone formation was also found in the central 
area of the unfilled CSD in the male rat. There was no 
inflammatory infiltration or multinucleated giant cells 
in relation to the biomaterial.
There were no statistically significant differences 
among the animals in relation to the gender.
- Histomorphometrical results
In Table 2, the mean surface of newly formed bone (in 
μm2) for ROIs of each animal was presented. There was 
a statistically significantly increase in the surface of 
newly formed bone in l1 (P=0.039) in the experimental 
group (91733.00±38855.60 μm2) compared to the control 
group (46762.17±25507.97 μm2) (Table 2). Within the 
experimental group, a statistically significant increase 
(P=0.042) in the surface of newly formed bone in l1 area 
was noticed in rats euthanized in 4th week compared 
with rats euthanized in 2nd week after surgery (Table 3).
In Table 4, the NOex-c in 2, 4 and 8 weeks after surgery 
is also presented. Τhere was a statistically significant 
increase (P=0.029) in this parameter in rats euthanized 
in 4th week post surgery (Table 4). 
There were no statistically significant differences 
among the animals in relation to the gender.
Discussion
In the present study new bone formation, as assessed by 
Weeks post surgery Newly formed bone Inflammatory infiltration Multinucleated giant cells Residual Biomaterial
2 + + + +++
4 +++ _ _ ++
8 + _ _ ++
Table 1. Histological parameters evaluated at 2, 4 and 8 weeks post surgery.
“- ” = not at all
“+” = a little bit
“++” = moderate
“+++” = very much
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Fig. 3. In rats euthanized at 2 weeks post surgery, newly formed bone was observed in the lateral areas 
inward (lateral 1, l1) and outward (lateral 2, l2) of the middle sagittal seam, while not in the central area 
of (A) experimental and (B) control group. In rats euthanized at 4 weeks after surgery, the number of 
osteocytes in new bone area was higher in (C) the experimental group, compared with (D) the control 








mean SD** SEM*** mean SD SEM
l1 91733.00 38855.60 15862.73 46762.17 25507.96 10413.58 0.039
l2 95828.33 83366.40 34034.19 76130.00 30122.87 12297.61 0.598
c 10040.50 24594.10 10040.50 12645.33 30974.61 12645.33 0.875
*l1=lateral 1, l2= lateral 2, c=central
**SD=Standard Deviation
***SEM=Standard Error Mean
Table 2. Surface of newly formed bone (in μm2) in lateral (l1, l2) and central (c) regions of interest in experimental and control 
group of all rats.









P-valuemean SD** SEM*** mean SD SEM mean SD SEM
l1 4338.5 4661.9 3296.5 17321.5 2669.3 1887.5 2964.5 2324.2 1643.5 0.042
l2 4340.0 5857.6 4142.0 12123.0 5235.4 3702.0 8558.0 4058.7 2870.0 0.422
c 0.0 0.0 0.0 6601.5 9335.9 6601.5 2495.0 3528.4 2495.0 0.575
Table 3. Newly bone formation (in μm2) in the experimental group in rats euthanized at 2nd, 4th and 8th week after surgery.
*l1=lateral 1, l2= lateral 2, c=central
**SD=Standard Deviation
***SEM=Standard Error Mean
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newly formed bone surface and total number of osteocytes, 
was seen in bilateral CSDs of 5mm-diameter in Sprague 
Dawley rats filled with 75/25 w/w nHAp/CS scaffolds.
CSD is “the smallest intrabony wound which does not 
heal spontaneously” (24). The proper CSD size for evalu-
ation of bone regenerative biomaterials in a rat calvarial 
defect model has not been determined and full-thickness 
CSDs of 5mm-diameter (21,23,25-29) or 8mm-diameter 
(22, 30-32) have been used. Full-thickness 5mm-diam-
eter defects simplify surgical procedure and allow the 
creation of bilateral defects, reducing rats’ mortality and 
morbidity (21,33), and consequently the total number of 
animals that are required (21). This experimental setting 
allowed the comparative histological and histomorpho-
metric analysis of the defects in the same animal in the 
current study. However, full-thickness 5mm-diameter 
unfilled defects may show bone formation at 8 weeks 
(34), as seen in the male rat euthanized at 8 weeks after 
surgery in the current study.
Histomorphometrical analysis is the gold standard for the 
assessment of new bone formation in rat calvarial CSDs 
(21,22,29). In this study, digital image analysis allowed 
an objective comparison of new bone formation among 
experimental and control CSDs, as estimated by the sur-
face of the newly formed bone and number of osteocytes.
The choice of both sexes in this study was made in 
agreement with the National Institute of Health (NIH) 
“Consideration of Sex as a Biological Variable in NIH-
funded Research” notice (NOT-OD-102) that has marked 
an over-reliance on male animals and cells in global re-
search. The use of both sexes also eliminates gender as 
a variable in the statistical analysis (32). No statistically 
significant difference in new bone formation surface was 
seen between male and female rats in our study. Howe-
ver, as the number of animals used was small, more stud-
ies are necessary to confirm this finding.
A study comparing micro-Hydroxyapatite/Chitosan 
(mHAp/CS) and nHAp/CS scaffolds showed that the 
total volume, bone volume, bone density and bone sur-
face was higher in nHAp/CS compared with mHAP/
CS scaffolds (35). Porous scaffolds based on nHAp/
CS are commonly used in tissue engineering applica-
tions. Those scaffolds have a highly porous structure 








mean SD* SEM** mean SD SEM mean SD SEM
43.0 22.6 16.0 230.5 41.7 29.5 142.5 37.4 26.5 0.029
*SD=Standard Deviation
**SEM=Standard Error Mean
Table 4. NOex-c, i.e. total number of osteocytes in newly formed bone surface in experimental group minus total number of osteocytes 
in newly formed bone surface in control group, in rats euthanized at 2nd, 4th and 8th week after surgery.
36), when the optimal size for bone ingrowth is 100μm 
to 400μm (37-41). In previous studies investigating the 
biological behavior of 80/20 w/w of nHAp/CS in rats, it 
was observed that when the hydroxyapatite concentration 
exceeded 80% the resulting scaffolds were friable (17). 
Therefore, Tsiourvas et al. (17) proposed that a ratio of 
nHAp/CS of 75/25 w/w with 90% porosity provided the 
scaffolds with improved physico-mechanical properties. 
In the present study a nHAp/CS of 75/25 w/w with 85±2% 
porosity, with pore size ranging between 20-100μm, was 
used and our findings support this proposal also from a 
“clinical” point of view, as during surgical procedure, the 
biomaterial was more easily cropped, handled, stuffed 
and covered by the tissue flaps in the CSDs.
Considering new bone formation, a statistically signifi-
cant increase was seen in the surface of the bone formed 
in the lateral regions of the defects between 2nd and 4th 
week. Those results are in agreement with previous 
studies (16,22,28,36). In addition, in the experimental 
group, a statistically significant increase was observed 
in the surface of newly formed bone in rats euthanized 
in 4th week compared to those euthanized in 2nd week 
after surgery, but not between the 4th and 8th week or the 
2nd and 8th week. Overall, the number of animals in each 
group was small for definite conclusions to be drawn.
In conclusion, scaffolds of nHAp/CS integrate bone tis-
sue and provide an effective space for new bone for-
mation. However, those results are not necessarily ap-
plicable to alveolar bone. Thus, further investigation 
of nHAp/CS scaffolds for GBR in oral and periodontal 
reconstructive procedures is required.
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